F S&P 500
5,076.50 +14.25 (+0.28%) F Dow Jones
38,100.00 +110.00 (+0.29%) F Nasdaq
17,710.50 +52.00 (+0.29%) E-mini Russell 2000 Index Futur
1,967.30 +5.30 (+0.27%) Petróleo
82.24 -0.45 (-0.54%) Oro
2,396.80 +8.40 (+0.35%)
ANI Pharmaceuticals, Inc. (ANIP)
Fuera de horario:
ANI Pharmaceuticals, Inc.
210 Main Street West
Baudette, MN 56623
United States
218 634 3500
https://www.anipharmaceuticals.com
Sector(es): Healthcare
Industria: Drug Manufacturers - Specialty & Generic
Empleados a tiempo completo: 642
Ejecutivos clave
| Nombre | Título | Pagar | Ejecutado | Año de nacimiento |
|---|---|---|---|---|
| Mr. Stephen P. Carey | Senior VP of Finance & CFO | 1.11M | N/D | 1971 |
| Mr. Chad Gassert | Senior Vice President of Corporate Development & Strategy | 849.71k | N/D | 1976 |
| Mr. Christopher K. Mutz | Senior Vp & Head of Rare Disease | 867.92k | N/D | 1972 |
| Mr. Ori Gutwerg | Senior Vice President of Generics | 895.16k | 436.25k | 1975 |
| Mr. James G. Marken | Senior Vice President of Operations & Product Development | 673.23k | N/D | 1963 |
| Ms. Meredith W. Cook | Senior VP, General Counsel & Corporate Secretary | N/D | N/D | 1975 |
| Ms. Krista L. Davis | Senior VP & Chief Human Resources Officer | N/D | N/D | 1974 |
| Ms. Elizabeth Powell J.D. | Chief Compliance Officer & Head of Legal of Rare Disease | N/D | N/D | N/D |
| Dr. Mary Pao M.D., Ph.D. | Chief Medical Officer | N/D | N/D | N/D |
| Mr. Thomas Andrew Rowland | Senior VP & Head of Established Brands | N/D | N/D | 1967 |
Descripción
ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. The company manufactures oral solid dose products; semi-solids, liquids, and topicals; controlled substances; and potent products, as well as performs contract development and manufacturing of pharmaceutical products. It markets its products through retail pharmacy chains, wholesalers, distributors and mail order pharmacies, group purchasing organizations, specialty pharmacies, and hospitals. ANI Pharmaceuticals, Inc. was incorporated in 2001 and is headquartered in Baudette, Minnesota.
Gestión corporativa
La calificación ISS Governance QuickScore de ANI Pharmaceuticals, Inc. a partir del 1 de abril de 2024 es 6. Las puntuaciones principales son Auditoría: 10; Junta: 5; Derechos del accionista: 6; Compensación: 4.
